Fig. 3

Percentage of patients with platelet aggregation of < 10% at different timepoints. ^*P < 0.001 vs. baseline; ^#P < 0.001 vs. ticagrelor group; ^&P < 0.001 vs. 24 h after eptifibatide discontinuation